Acebutolol is a beta adrenoceptor antagonist which is cardioselective, i.e. acts preferentially on beta-1 adrenergic receptors in the heart. Its principal effects are to reduce heart rate especially on exercise and to lower blood pressure in hypertensive subjects.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Acebutolol is the active ingredient of these drugs:
France South Africa Tunisia United Kingdom
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):